ECSP099089A - Composiciones farmaceuticas que contienen un anticuerpo monoclonal anti-idiotipico anti-ca-125 y derivados de aluminio - Google Patents

Composiciones farmaceuticas que contienen un anticuerpo monoclonal anti-idiotipico anti-ca-125 y derivados de aluminio

Info

Publication number
ECSP099089A
ECSP099089A EC2009009089A ECSP099089A ECSP099089A EC SP099089 A ECSP099089 A EC SP099089A EC 2009009089 A EC2009009089 A EC 2009009089A EC SP099089 A ECSP099089 A EC SP099089A EC SP099089 A ECSP099089 A EC SP099089A
Authority
EC
Ecuador
Prior art keywords
pharmaceutical compositions
monoclonal antibody
idiotipic
compositions containing
aluminum derivatives
Prior art date
Application number
EC2009009089A
Other languages
English (en)
Inventor
Reinhard Schmitz
Jens Flemming
Karsten Groeger
Stefano Manzini
Original Assignee
Menarini Int Operations Lu Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Menarini Int Operations Lu Sa filed Critical Menarini Int Operations Lu Sa
Publication of ECSP099089A publication Critical patent/ECSP099089A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A61K39/39566—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against immunoglobulins, e.g. anti-idiotypic antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La presente invención se refiere a composiciones farmacéuticas para administración parenteral como vacunas que comprenden un anticuerpo monoclonal y como adyuvante un derivado de aluminio.
EC2009009089A 2006-06-29 2009-01-26 Composiciones farmaceuticas que contienen un anticuerpo monoclonal anti-idiotipico anti-ca-125 y derivados de aluminio ECSP099089A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT000163A ITFI20060163A1 (it) 2006-06-29 2006-06-29 Composizione farmaceutica contenente un anticorpo monoclonale anti idiotipico anti-ca-125 ed alluminio

Publications (1)

Publication Number Publication Date
ECSP099089A true ECSP099089A (es) 2009-02-27

Family

ID=37439367

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2009009089A ECSP099089A (es) 2006-06-29 2009-01-26 Composiciones farmaceuticas que contienen un anticuerpo monoclonal anti-idiotipico anti-ca-125 y derivados de aluminio

Country Status (35)

Country Link
US (2) US20100040625A1 (es)
EP (2) EP2040749B1 (es)
JP (1) JP2009541448A (es)
KR (1) KR20090024240A (es)
CN (1) CN101478987A (es)
AP (1) AP2009004741A0 (es)
AR (1) AR061364A1 (es)
AT (1) ATE502649T1 (es)
AU (1) AU2007263690A1 (es)
BR (1) BRPI0713343A2 (es)
CA (1) CA2655733A1 (es)
CL (1) CL2007001888A1 (es)
CR (1) CR10589A (es)
CY (1) CY1111527T1 (es)
DE (1) DE602007013402D1 (es)
DK (1) DK2040749T3 (es)
EA (1) EA015543B1 (es)
EC (1) ECSP099089A (es)
ES (1) ES2363616T3 (es)
HK (1) HK1126417A1 (es)
HR (1) HRP20110413T1 (es)
IL (1) IL196148A0 (es)
IT (1) ITFI20060163A1 (es)
MA (1) MA30691B1 (es)
MX (1) MX2008016059A (es)
NO (1) NO20090395L (es)
PE (1) PE20080269A1 (es)
PL (1) PL2040749T3 (es)
PT (1) PT2040749E (es)
RS (1) RS51683B (es)
SI (1) SI2040749T1 (es)
TN (1) TNSN08485A1 (es)
UA (1) UA95806C2 (es)
WO (1) WO2008000789A2 (es)
ZA (1) ZA200900563B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20160279239A1 (en) 2011-05-02 2016-09-29 Immunomedics, Inc. Subcutaneous administration of anti-cd74 antibody for systemic lupus erythematosus and autoimmune disease
US20160355591A1 (en) 2011-05-02 2016-12-08 Immunomedics, Inc. Subcutaneous anti-hla-dr monoclonal antibody for treatment of hematologic malignancies
ITFI20060163A1 (it) * 2006-06-29 2006-09-28 Menarini Internat Operations Luxembourg Sa Composizione farmaceutica contenente un anticorpo monoclonale anti idiotipico anti-ca-125 ed alluminio
AU2012250924B2 (en) 2011-05-02 2017-05-25 Immunomedics, Inc. Ultrafiltration concentration of allotype selected antibodies for small-volume administration
CN110352201A (zh) 2017-04-03 2019-10-18 免疫医疗公司 用于癌症疗法的抗体药物缀合物的皮下施用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5127731B1 (es) * 1971-05-12 1976-08-14
FR2565825B1 (fr) * 1984-06-15 1990-07-13 Centre Nat Rech Scient Vaccin contre les maladies dues a des microorganismes tels que des mycoplasmes, sa preparation et membranes de microorganismes en tant que principe actif
CA2163868C (en) 1993-05-27 2008-01-08 Uwe Wagner Monoclonal anti-idiotypic anti-ca125 antibodies and pharmaceutical compositions containing them
US5690942A (en) * 1995-06-02 1997-11-25 American Home Products Corporation Adjuvants for viral vaccines
US5718904A (en) * 1995-06-02 1998-02-17 American Home Products Corporation Adjuvants for viral vaccines
GB9808485D0 (en) * 1998-04-21 1998-06-17 Univ Cambridge Tech Improvements relating to immunotherapy
US6586403B1 (en) * 2000-07-20 2003-07-01 Salpep Biotechnology, Inc. Treating allergic reactions and inflammatory responses with tri-and dipeptides
US6585981B1 (en) * 2000-07-27 2003-07-01 Regents Of The University Of Minnesota Temperature-sensitive live vaccine for Mycoplasma hyopneumoniae
CU23007A1 (es) * 2001-04-06 2004-12-17 Ct De Inmunologia Molecular Ct De Inmunologia Mole Combinaciones inmunoterapéuticas para el tratamiencombinaciones inmunoterapéuticas para el tratamiento de tumores que sobre-expresan gangliósidos to de tumores que sobre-expresan gangliósidos
US7537767B2 (en) * 2003-03-26 2009-05-26 Cytis Biotechnology Ag Melan-A- carrier conjugates
ITFI20060163A1 (it) * 2006-06-29 2006-09-28 Menarini Internat Operations Luxembourg Sa Composizione farmaceutica contenente un anticorpo monoclonale anti idiotipico anti-ca-125 ed alluminio

Also Published As

Publication number Publication date
KR20090024240A (ko) 2009-03-06
US20090104184A1 (en) 2009-04-23
BRPI0713343A2 (pt) 2012-03-13
AR061364A1 (es) 2008-08-20
RS51683B (en) 2011-10-31
ITFI20060163A1 (it) 2006-09-28
EP2228073A1 (en) 2010-09-15
CR10589A (es) 2009-03-30
TNSN08485A1 (en) 2010-04-14
HK1126417A1 (en) 2009-09-04
EA200900085A1 (ru) 2009-06-30
PT2040749E (pt) 2011-06-30
EP2040749A2 (en) 2009-04-01
WO2008000789A2 (en) 2008-01-03
ES2363616T3 (es) 2011-08-10
EA015543B1 (ru) 2011-08-30
CL2007001888A1 (es) 2008-04-18
MX2008016059A (es) 2009-01-15
ZA200900563B (en) 2010-03-31
DK2040749T3 (da) 2011-06-14
EP2040749B1 (en) 2011-03-23
SI2040749T1 (sl) 2011-06-30
ATE502649T1 (de) 2011-04-15
DE602007013402D1 (de) 2011-05-05
PL2040749T3 (pl) 2011-09-30
NO20090395L (no) 2009-01-27
IL196148A0 (en) 2011-08-01
HRP20110413T1 (hr) 2011-07-31
AP2009004741A0 (en) 2009-02-28
CN101478987A (zh) 2009-07-08
JP2009541448A (ja) 2009-11-26
UA95806C2 (ru) 2011-09-12
PE20080269A1 (es) 2008-05-09
AU2007263690A1 (en) 2008-01-03
CY1111527T1 (el) 2015-08-05
MA30691B1 (fr) 2009-09-01
CA2655733A1 (en) 2008-01-03
WO2008000789A3 (en) 2008-02-28
US20100040625A1 (en) 2010-02-18

Similar Documents

Publication Publication Date Title
ECSP099721A (es) Inhibidores de cinasa p70 s6
BR112017019300A2 (pt) conjugado de fórmula genérica ama - l - x - s - ab, método para sintetizar um conjugado de fórmula genérica ama - l - x - s - ab, kit, método para sintetizar o composto ama - l - x', composição farmacêutica e método para tratar uma doença associada a células que apresentam um alvo
CR20110035A (es) Composiciones y Métodos para Anticuerpos que se dirigen a la Proteína de Complemento C5
CR20110166A (es) Anticuerpos biespecíficos anti-vegf/anti-ang-2
CR20150228A (es) Inhibidores de la tirosina-quinasa de bruton
CL2010001426A1 (es) Compuestos derivados de triciclos, inhibidores de la proteina quinasa; composicion farmaceutica que los comprende; utiles en el tratamiento de enfermedades oncologicas e inmunologicas.
CR20110466A (es) Anticuerpos biespecíficos anti-erbb-3/anti-c-met
BR112013023015A8 (pt) conjugado de amatoxina e seu uso, composição farmacêutica e seu uso, molécula de conjugação de amatoxina, método para a síntese de um conjungado de amatoxina.
CO6321189A2 (es) Compuestos de tiazol y oxazol de bencen-sulfonamida
BRPI0815170A2 (pt) Composição farmacêutica que compreende um inibidor de sglt 2
CO6341565A2 (es) Inhibidores macrociclicos de serina proteasas de hepatitis c
CR11427A (es) 2-fluoro-2 - desoxitetrahidrouridinas como inhibidores de citidina desaminasa
CL2011002943A1 (es) Anticuerpo triespecifico o tetraespecifico; metodo para la preparacion de dicho anticuerpo; celula huesped; composicion farmaceutica.
BR112013007577A2 (pt) conjugado, composição farmacêutica, molécula de conjugação com amatoxina e método para a síntese de um conjugado
BRPI0813892A2 (pt) composições que compreendem antígenos pneumococcal
BR112016008576A2 (pt) Formulações aquosas estáveis de anticorpos e forma farmacêutica de dosagem unitária
GT201000023A (es) Nuevos derivados de 6-trialzolopiridacina-sulfanil benzotiazol y bencimidazol, su procedimiento de preparacion, su aplicacion como medicamentos, composiciones farmaceuticas y nueva utilizacion principalmente como inhibidores de met.
BR112013007362A2 (pt) composição farmacêutica
CL2008001258A1 (es) Kit de vacuna que comprende al menos nueve conjugados de sacaridos de antgenos hb o hib, donde al menos 2-7 son con la proteina transportadora crm, siendo dicho kit adecuado para usar en su calendario de inmunizacion primaria; vacuna combinada adecuada para la inmunizacion primaria.
DK2254549T3 (da) Vandige farmaceutiske sammensætninger, indeholdende borat-polyol-komplekser
HN2011001247A (es) Inhibidores de cinana akt y p70 s6
BR112016011755A2 (pt) derivado de ureia ou sal farmacologicamente aceitável do mesmo
GT200900192A (es) Derivados de imidazol como inhibidores de proteina de uso de cinesina (eg-5).-
BR112012011328A2 (pt) inibidores de akt
HN2008001723A (es) Nitrilos espirociclicos como inhibidores de proteasa